Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-24
1996-06-11
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514428, 546205, 548567, A61K 31445, A61K 3140, C07D21106, C07D20709
Patent
active
055256171
ABSTRACT:
Fibrinogen receptor antagonists having the formula ##STR1## for example ##STR2##
REFERENCES:
patent: 4069326 (1978-01-01), Teulon
patent: 4647559 (1987-03-01), Kuhla
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5272158 (1993-12-01), Hartman et al.
patent: 5274098 (1993-12-01), Stuer
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5292756 (1994-03-01), Duggan et al.
patent: 5294616 (1994-03-01), Duggan et al.
patent: 5321034 (1994-06-01), Duggan et al.
Birchenough Laura
Egbertson Melissa S.
Hartman George D.
Vassallo Laura
Chang Ceila
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-351857